Reports and Presentations

Unaudited Interim Results for six months to 31 March 2026

Group Revenue

£20.7m

(prior-year period: £20.1m)

H1 Group Adjusted EBIT*

(£0.2m)

(prior-year period: (£0.4m))

Group Cash

£31.7m

(prior-year period: £39.9m)

Results highlights

Group Revenue

£20.7m

Revenues for the Group increased by 3% to £20.7m (prior-year period: £20.1m), in line with management expectations and reflecting an improved year-on-year performance

Group Adjusted EBIT*

(£0.2m)

Adjusted EBIT improved by 50% to a loss of £0.2m (prior-year period: loss of £0.4m), reflecting higher revenue, robust gross margin and continued cost control

Group Net Cash

£31.7m

Strong balance sheet with cash and fixed term deposits of £31.7m (prior-year period: £39.9m), after payment of final dividend of £3.7m and share buybacks of £1.3m in period; substantial resources available for further targeted M&A

Operational Cash Generation

£1.1m

Cash generated from operating activities before tax was £1.1m (prior-year period: £3.1m); further optimisation of working capital and cash management expected through remainder of financial year

CFO comment

The Group is reporting revenue of £20.7m (prior-year period: £20.1m) and Adjusted EBIT* of (£0.2m) (prior-year period: (£0.4m)), in line with management expectations, and reflecting a year-on-year improvement in revenues and profitability. This growth was driven by Motion Capture’s 10% increase in revenue as well as an improved gross margin and strong cost controls. In Vision Metrology, revenue was impacted by delayed orders, though cost efficiencies helped mitigate lower sales. 

Cash generated from operations before tax was £1.1m (prior-year period: £3.1m). We continue to concentrate on improvements to working capital and the optimisation and right-sizing of inventory, which saw a further small decrease in the period.

In addition to a strong performance in Motion Capture, the Group completed the combination of the IVS and Sempre businesses, now reported under the Vision Metrology division. This consolidation has delivered a step change in scale and capability and has enabled the Group to streamline processes, align systems, and optimise resources, supporting improved operational efficiency and a more cohesive go-to-market strategy. 

Enabled by its strong cash balance, the Group continues to adopt a selective and disciplined approach to M&A, targeting earnings-enhancing deals that add accelerative IP, technology or market reach in Vision Metrology and IP-enhancing opportunities in Motion Capture. 

*Adjusted EBIT is earnings before interest and tax, adjusted for share-based payment charges, amortisation of acquired intangibles, costs and impairments relating to closure of IMU New Zealand, impairment of development costs and additional costs related to restructuring and acquisitions.

Research

Analyst coverage for Oxford Metrics is provided by:

  • Panmure Liberum - Harvey Robinson
  • Progressive Equity Research - Ian Robertson
  • Canaccord Genuity - Hayley Palmer

To ensure that all shareholders and potential shareholders have access to research commentary, Oxford Metrics has commissioned Progressive Equity Research to publish research on the Company.

Financial calendar 2026

25 Feb

AGM

27 Mar

Dividend date

31 Mar

End of H1

31 Dec

End of H2

Oxford Metrics